Literature DB >> 20576929

Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia.

Ken Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20576929     DOI： 10.1093/jnci/djq262

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  20 in total

Review 1.  Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Authors:  Wan Zhang; Peng Huang
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

2.  Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer.

Authors:  Fangrui Wu; Gang Cheng; Yuan Yao; Mari Kogiso; Hong Jiang; Xiao-Nan Li; Yongcheng Song
Journal:  Med Chem       Date:  2018       Impact factor: 2.745

3.  Ten-Eleven Translocation-2 gene mutations: A potential new molecular marker in malignant gliomas (Review).

Authors:  Lei Yu; Songtao Qi
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

Review 4.  The molecular basis for novel therapies.

Authors:  Jethro Hu; Santosh Kesari
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

5.  A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.

Authors:  Cole R Drifka; Kevin W Eliceiri; Sharon M Weber; W John Kao
Journal:  Lab Chip       Date:  2013-10-07       Impact factor: 6.799

6.  Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase.

Authors:  Baisong Zheng; Yuan Yao; Zhen Liu; Lisheng Deng; Justin L Anglin; Hong Jiang; B V Venkataram Prasad; Yongcheng Song
Journal:  ACS Med Chem Lett       Date:  2013-06-13       Impact factor: 4.345

7.  Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation.

Authors:  Jelena Lazovic; Horacio Soto; David Piccioni; Jerry R Lou; Sichen Li; Leili Mirsadraei; William Yong; Robert Prins; Linda M Liau; Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

8.  Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.

Authors:  Ramon F Barajas; Bronwyn E Hamilton; Daniel Schwartz; Heather L McConnell; David R Pettersson; Andrea Horvath; Laszlo Szidonya; Csanad G Varallyay; Jenny Firkins; Jerry J Jaboin; Charlotte D Kubicky; Ahmed M Raslan; Aclan Dogan; Justin S Cetas; Jeremy Ciporen; Seunggu J Han; Prakash Ambady; Leslie L Muldoon; Randy Woltjer; William D Rooney; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

9.  Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds.

Authors:  Fangrui Wu; Hong Jiang; Baisong Zheng; Mari Kogiso; Yuan Yao; Chao Zhou; Xiao-Nan Li; Yongcheng Song
Journal:  J Med Chem       Date:  2015-08-26       Impact factor: 7.446

10.  The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.

Authors:  Mohammed Goryawala; Efrat Saraf-Lavi; Natalia Nagornaya; Deborah Heros; Ricardo Komotar; Andrew A Maudsley
Journal:  J Neuroimaging       Date:  2019-12-23       Impact factor: 2.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.